Skip to content
10-Q

Quarterly Report

Prime Medicine, Inc. PRME

0001628280-25-038619

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 134.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 129.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 128.44M sh
Shares Diluted Q2 2025 · Jun 30, 2024 119.19M sh
Shares Diluted Q2 2025 · Jun 30, 2024 111.83M sh
Capex Q2 2025 · Jun 30, 2025 $3.99M
Capex Q2 2025 · Jun 30, 2024 $4.23M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$90.27M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$113.2M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $53.8M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $182.48M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $55.6M
Stockholders Equity Q2 2025 · Jun 30, 2025 $60.86M
Stockholders Equity Q2 2025 · Mar 31, 2025 $106.92M
Stockholders Equity Q2 2025 · Dec 31, 2024 $153.15M
Stockholders Equity Q2 2025 · Jun 30, 2024 $196.59M
Stockholders Equity Q2 2025 · Mar 31, 2024 $243.77M
Stockholders Equity Q2 2025 · Dec 31, 2023 $133.07M
Current Liabilities Q2 2025 · Jun 30, 2025 $34.11M
Current Liabilities Q2 2025 · Dec 31, 2024 $37.96M
Total Liabilities Q2 2025 · Jun 30, 2025 $218.15M
Total Liabilities Q2 2025 · Dec 31, 2024 $144.36M
Current Assets Q2 2025 · Jun 30, 2025 $121.29M
Current Assets Q2 2025 · Dec 31, 2024 $211.89M
Total Assets Q2 2025 · Jun 30, 2025 $279.01M
Total Assets Q2 2025 · Dec 31, 2024 $297.51M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.41
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.81
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.90
Eps Basic Q2 2025 · Jun 30, 2025 −$0.41
Eps Basic Q2 2025 · Jun 30, 2025 −$0.81
Eps Basic Q2 2025 · Jun 30, 2024 −$0.46
Eps Basic Q2 2025 · Jun 30, 2024 −$0.90
Sga Expense Q2 2025 · Jun 30, 2025 $13.12M
Sga Expense Q2 2025 · Jun 30, 2025 $26.4M
Sga Expense Q2 2025 · Jun 30, 2024 $12.6M
Sga Expense Q2 2025 · Jun 30, 2024 $23.76M
Rd Expense Q2 2025 · Jun 30, 2025 $41.38M
Rd Expense Q2 2025 · Jun 30, 2025 $81.94M
Rd Expense Q2 2025 · Jun 30, 2024 $43.07M
Rd Expense Q2 2025 · Jun 30, 2024 $80.85M
Net Income Q2 2025 · Jun 30, 2025 −$52.59M
Net Income Q2 2025 · Jun 30, 2025 −$104.48M
Net Income Q2 2025 · Mar 31, 2025 −$51.89M
Net Income Q2 2025 · Jun 30, 2024 −$55.33M
Net Income Q2 2025 · Jun 30, 2024 −$101.09M
Net Income Q2 2025 · Mar 31, 2024 −$45.76M
Operating Income Q2 2025 · Jun 30, 2025 −$53.38M
Operating Income Q2 2025 · Jun 30, 2025 −$105.77M
Operating Income Q2 2025 · Jun 30, 2024 −$55.67M
Operating Income Q2 2025 · Jun 30, 2024 −$104.01M
Revenue Q2 2025 · Jun 30, 2025 $1.12M
Revenue Q2 2025 · Jun 30, 2025 $2.57M
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $591K